Advanced Biomed Inc.
ADVB
$0.42
$0.001.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 287.90K | 978.30K | 512.30K | 282.30K | 338.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 523.90K | 1.21M | 762.70K | 525.70K | 520.00K |
| Operating Income | -523.90K | -1.21M | -762.70K | -525.70K | -520.00K |
| Income Before Tax | -386.90K | -701.60K | -1.38M | -907.90K | -265.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -386.90K | -701.60K | -1.38M | -907.90K | -265.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -386.90K | -701.60K | -1.38M | -907.90K | -265.60K |
| EBIT | -523.90K | -1.21M | -762.70K | -525.70K | -520.00K |
| EBITDA | -475.90K | -1.15M | -684.60K | -426.70K | -417.80K |
| EPS Basic | -0.02 | -0.03 | -0.07 | -0.05 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.04 | -0.03 | -0.01 |
| EPS Diluted | -0.02 | -0.03 | -0.07 | -0.05 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.04 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 21.64M | 21.63M | 20.48M | 20.00M | 20.00M |
| Average Diluted Shares Outstanding | 21.64M | 21.63M | 20.48M | 20.00M | 20.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |